Researchers develop new treatment for bone infection using copper-rich glass implant

RCSI researchers develop new treatment for bone infection using copper-rich glass implant
The study's first author Emily Ryan, a recently qualified PhD student in the RCSI Department of Anatomy, pictured with Prof Fergal O'Brien, Professor of Bioengineering & Regenerative Medicine in the RCSI Department of Anatomy, Head of the Tissue Engineering Research Group and Deputy Director of AMBER the SFI Research Centre for materials science. Credit: RCSI

A team of researchers led by RCSI (Royal College of Surgeons in Ireland), have developed a new treatment for the particularly difficult-to-treat bone infection, osteomyelitis.

Funded by Irish Research Council, European Research Council and AMBER, the SFI (Science Foundation Ireland) research centre for materials science, the study is published in Biomaterials, the No. 1 ranked scientific journal in the field.

The new treatment has developed a one-step solution that kills bacteria and promotes without using antibiotics. To do this, researchers combined copper particles with bioactive glass—a type of glass used for repair—and incorporated it into an implant designed specifically for bone repair.

The copper-doped in the porous scaffold implant attracts and bone cells, which accelerates bone repair. The copper ions in the implant also prevent bacteria growth. The ability of a single implant to improve blood flow and enhance bone healing as well as inhibit infection without antibiotic treatment is a significant advancement over most existing treatments.

"Osteomyelitis is notoriously difficult to treat. Further work on the back of this research could lead to the complete development of a single-stage, off-the-shelf treatment. This in turn could reduce the need for antibiotics and bone grafting—thus also addressing issues with " said first author Emily Ryan, a recently qualified Ph.D. student in the RCSI Department of Anatomy.

People can develop this from broken bones, severe tooth decay and deep puncture wounds, among other causes. In the worst cases, osteomyelitis can result in amputations or be fatal.

The current treatment for osteomyelitis:

  • Usually involves weeks of high-dose antibiotic therapy,
  • Often requires removing infected through surgery,
  • May require bone grafting,
  • Has a failure rate of up to 30%.

"We are looking forward to developing and testing this treatment for osteomyelitis and for other infections too. This platform system could be further modified and used to deliver a variety of other non-antibiotic antimicrobial metal ion-doped minerals," said Principal Investigator, Prof Fergal O'Brien, Professor of Bioengineering & Regenerative Medicine in the RCSI Department of Anatomy, Head of the Tissue Engineering Research Group and Deputy Director of the AMBER Research Centre.


Explore further

Bone apetit: How bacteria eat bone to sustain invasive infection

More information: Emily J. Ryan et al, Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo, Biomaterials (2019). DOI: 10.1016/j.biomaterials.2019.01.031
Journal information: Biomaterials

Provided by RCSI
Citation: Researchers develop new treatment for bone infection using copper-rich glass implant (2019, January 30) retrieved 17 October 2019 from https://phys.org/news/2019-01-treatment-bone-infection-copper-rich-glass.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments

Jan 30, 2019
Bravo !
Could this be combined with joint replacements, or would the presence of the copper corrode the prosthetic ??

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more